BCL-2 | BCL-X | BAX | MCL-1 | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Initial | Recurrence | Initial | Recurrence | Initial | Recurrence | Initial | Recurrence | ||||||||
Whole group (n=37) | 15 | 19 | 20 | 25 | 14 | 11 | 10 | 11 | |||||||
Quartiles | 13–16 | 16–22 | 15–23 | 23–29 | 11–15 | 10–12 | 10–11 | 10–13 | |||||||
p Value | < 0.0001 | < 0.0001 | < 0.0001 | 0.0395 | |||||||||||
Radiochemoth (n=15) | 14 | 19 | 18 | 25 | 12 | 11 | 10 | 11 | |||||||
Quartiles | 12.5–15 | 17.5–20.5 | 12–24 | 22–28 | 10.5–16 | 10–11 | 10–11.5 | 10–13 | |||||||
p Value | 0.0012 | 0.0031 | 0.0122 | 0.0977 | |||||||||||
Radiotherapy (n=15) | 15 | 17 | 20 | 22 | 14 | 12 | 10 | 11 | |||||||
Quartiles | 13–18 | 15.5–22.5 | 15–23 | 17.5–30 | 11–14 | 10.5–13 | 10–11 | 10.5–13 | |||||||
p Value | 0.0125 | 0.081 | 0.2402 | 0.0186 | |||||||||||
Untreated (n=7) | 15 | 22 | 22 | 29 | 15 | 12 | 11.00 | 11.00 | |||||||
Quartiles | 14–16 | 14–26 | 19–24.5 | 24.5–29.5 | 11.5–16.5 | 12–15 | 11–15.5 | 11–13.5 | |||||||
p Value | 0.0781 | 0.3125 | 0.4375 | 0.6250 |
According to the Bonferroni method, only p values <0.017 are presumed to be significant at the 0.05 level in the subgroups.